Combining protein and DNA engineering to create bioswitches
结合蛋白质和 DNA 工程来创建生物开关
基本信息
- 批准号:10561100
- 负责人:
- 金额:$ 43.59万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-20 至 2026-08-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAntibodiesBCAR1 geneBacillus amyloliquefaciens ribonucleaseBase SequenceBindingBiologicalBiological MarkersBiologyBiophysicsBiosensorBone Marrow Stem CellCalciumCalcium SignalingCalmodulinCause of DeathCellsCellular PhoneClustered Regularly Interspaced Short Palindromic RepeatsComplexComputing MethodologiesCytomegalovirusDNADNA BindingDNA Binding DomainDNA SequenceDevicesDiseaseDisease MarkerEngineeringEnzymesExhibitsEyeFamilyFibronectinsFluorescenceFluorescence Resonance Energy TransferGenesGoalsGuide RNAHumanHuman ActivitiesImmunocompromised HostIndividualKineticsLigand BindingLigandsMediatingMethodologyModificationMolecular ConformationMonitorMorbidity - disease rateNatureNucleic Acid BindingNucleic AcidsOutcomeOutputPathway interactionsProtein ConformationProtein EngineeringProtein FamilyProteinsProteomeRNARNA BindingRNA SequencesReaction TimeRegulationResearchRibonucleasesSourceSystemTechnologyTherapeuticToxinTransplant RecipientsTransplantationVariantViralaptamerbasecombinatorialcytotoxicdesignexperimental studyfrontierlink proteinluminescencemonocytemortalitynanoluciferasepathogenpoint-of-care detectionpreventprotein foldingprotein functionratiometricresponsescaffoldsensorsimulationsmall moleculetool
项目摘要
Project Summary and Relevance
The goal of this project is to develop mechanisms by which ordinary proteins can be turned into ligand-
activated conformational switches. When naturally-occurring proteins of this type are discovered, their
engineering can result in technologies that transform biology. For example, CRISPR-associated protein
catalytic activity is switched on by binding of guide RNA, and calmodulin undergoes a large conformational
change upon ligating calcium. Developing these proteins into DNA manipulation tools and fluorescent calcium
sensors, respectively have revolutionized gene editing and the study of calcium signaling. The current proposal
asks the question, “what else is possible if other proteins and enzymes can be made to switch on/off by binding
of DNA, RNA, or other ligands?”.
The proposed project takes a combined biophysical, computational, and cellular approach to develop a
general mechanism for linking protein function to ligand binding. Three families of protein switches will be
created. The first is a biosensor that plugs into existing DNA tools (such as aptamers and toehold-mediated
strand displacement hairpins) without any modification to the sensor, to detect a DNA or RNA sequence of
choice. The output is ratiometric (blue/green) luminescence that can be detected by cell phone camera. The
second family employs fibronectin 3 ‘monobodies’ as the input domains and fluorescent proteins as the output
domains to provide a ratiometric FRET response, or large increase in fluorescence intensity, when
encountering an intracellular target. In the third switch design, the enzymatic activity of a bacterial RNase is
turned on by cytomegalovirus (CMV) RNA to kill CMV-infected human cells. This last aim addresses the
pressing need of preventing transplant-related CMV disease.
Relevance. This study will open the biological activity of the human proteome to potential regulation by
binding of nucleic acids, proteins, and small molecules. The modular design allows mixing and matching of
different proteins to generate molecules with functionalities not found in nature. Examples include biosensors
for pathogens and disease biomarkers, and an enzyme that kills virally-infected human cells while leaving
uninfected cells unharmed.
项目摘要和相关性
该项目的目标是开发普通蛋白质可以转化为配体的机制-
激活构象转换当这种类型的天然蛋白质被发现时,
工程学可以产生改变生物学的技术。例如,CRISPR相关蛋白
催化活性通过引导RNA的结合而开启,并且钙调蛋白经历大的构象变化。
在结扎钙后的变化。将这些蛋白质开发成DNA操纵工具和荧光钙
传感器,分别彻底改变了基因编辑和钙信号的研究。现时的建议
提出了一个问题,“如果其他蛋白质和酶可以通过结合来打开/关闭,
DNA、RNA或其他配体?”
拟议的项目采用生物物理,计算和细胞相结合的方法来开发一种
蛋白质功能与配体结合的一般机制。三个蛋白质开关家族将被
创造第一种是插入现有DNA工具(例如适体和立足点介导)的生物传感器
链置换发夹),而不对传感器进行任何修饰,以检测
选择输出为比率(蓝色/绿色)发光,可由手机摄像头检测。的
第二个家族采用纤连蛋白3“单体”作为输入结构域,荧光蛋白作为输出
结构域提供比率FRET响应,或荧光强度的大幅增加,当
遇到细胞内目标在第三种开关设计中,细菌RNA酶的酶活性是
由巨细胞病毒(CMV)RNA打开,杀死CMV感染的人类细胞。最后一个目标是解决
迫切需要预防与移植相关的CMV疾病。
本案无关这项研究将开放人类蛋白质组的生物活性,通过
核酸、蛋白质和小分子的结合。模块化设计允许混合和匹配
不同的蛋白质,以产生分子的功能,没有发现在自然界中。例子包括生物传感器
病原体和疾病的生物标志物,以及一种酶,杀死病毒感染的人体细胞,同时离开
未受感染的细胞毫发无伤
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
STEWART N LOH其他文献
STEWART N LOH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('STEWART N LOH', 18)}}的其他基金
Combining protein and DNA engineering to create bioswitches
结合蛋白质和 DNA 工程来创建生物开关
- 批准号:
10707393 - 财政年份:2022
- 资助金额:
$ 43.59万 - 项目类别:
Mechanism and detection of LECT2 amyloidosis
LECT2淀粉样变性的机制及检测
- 批准号:
10475334 - 财政年份:2021
- 资助金额:
$ 43.59万 - 项目类别:
Targeted Destruction of HIV and HIV-Infected Cells by an Engineered Ribonuclease
通过工程核糖核酸酶靶向破坏 HIV 和 HIV 感染细胞
- 批准号:
7414887 - 财政年份:2007
- 资助金额:
$ 43.59万 - 项目类别:
Targeted Destruction of HIV and HIV-Infected Cells by an Engineered Ribonuclease
通过工程核糖核酸酶靶向破坏 HIV 和 HIV 感染细胞
- 批准号:
7283356 - 财政年份:2007
- 资助金额:
$ 43.59万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 43.59万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 43.59万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 43.59万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 43.59万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 43.59万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 43.59万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 43.59万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 43.59万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 43.59万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 43.59万 - 项目类别:














{{item.name}}会员




